157 related articles for article (PubMed ID: 32014448)
21. Methamphetamine enhances caveolar transport of therapeutic agents across the rodent blood-brain barrier.
Chang JH; Greene C; Frudd K; Araujo Dos Santos L; Futter C; Nichols BJ; Campbell M; Turowski P
Cell Rep Med; 2022 Jan; 3(1):100497. PubMed ID: 35106509
[TBL] [Abstract][Full Text] [Related]
22. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
Duan M; Xing Y; Guo J; Chen H; Zhang R
Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
[TBL] [Abstract][Full Text] [Related]
23. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
24. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
25. DT(270-326) , a Truncated Diphtheria Toxin, Increases Blood-Tumor Barrier Permeability by Upregulating the Expression of Caveolin-1.
Lin Y; Wang P; Liu YH; Shang XL; Chen LY; Xue YX
CNS Neurosci Ther; 2016 Jun; 22(6):477-87. PubMed ID: 26861687
[TBL] [Abstract][Full Text] [Related]
26. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.
Mu R; Sun H; Zeng Y; Tong Y; Tang P; Zhao M; Lv Z; Yu J; Chen Y; Lan Q; Zhen X; Han L
J Control Release; 2024 May; 369():458-474. PubMed ID: 38575077
[TBL] [Abstract][Full Text] [Related]
27. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
[TBL] [Abstract][Full Text] [Related]
28. Salvianolic acid A ameliorates the integrity of blood-spinal cord barrier via miR-101/Cul3/Nrf2/HO-1 signaling pathway.
Yu DS; Wang YS; Bi YL; Guo ZP; Yuan YJ; Tong SM; Su RC; Ge LH; Wang J; Pan YL; Guan TT; Cao Y
Brain Res; 2017 Feb; 1657():279-287. PubMed ID: 28011395
[TBL] [Abstract][Full Text] [Related]
29. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
30. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
31. Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells.
Shajahan AN; Tiruppathi C; Smrcka AV; Malik AB; Minshall RD
J Biol Chem; 2004 Nov; 279(46):48055-62. PubMed ID: 15345719
[TBL] [Abstract][Full Text] [Related]
32. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
[TBL] [Abstract][Full Text] [Related]
33. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
34. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
35. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y
Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
[TBL] [Abstract][Full Text] [Related]
38. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
39. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/ETV1 axis.
Li H; Shen S; Ruan X; Liu X; Zheng J; Liu Y; Yang C; Wang D; Liu L; Ma J; Ma T; Wang P; Cai H; Li Z; Zhao L; Xue Y
Cell Death Dis; 2019 Dec; 10(12):960. PubMed ID: 31862871
[TBL] [Abstract][Full Text] [Related]
40. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
